Testosterone Injections: Why Twice-Weekly Dosing and Subcutaneous Administration Offer Clear Advantages

Testosterone
Written By Chris Lyons

At Affinity Whole Health, we personalize testosterone replacement therapy (TRT) to optimize results while minimizing side effects. We exclusively use testosterone cypionate injections - one of the most effective, flexible, and well-studied options for men with clinically confirmed testosterone deficiency. Two practical decisions make a meaningful difference in day-to-day outcomes: injection frequency and injection route.

Here’s what the published data show about twice-weekly dosing and subcutaneous (subQ) versus intramuscular (IM) administration of testosterone cypionate.

Why Twice-Weekly Dosing Is an Advantage

Traditional protocols often use larger doses of testosterone cypionate every 1–2 weeks. While effective at raising average testosterone levels, this approach creates pronounced peaks and troughs.

After a larger, less frequent injection, serum testosterone rises into the high or even supraphysiologic range for several days, then declines toward the lower end of (or below) the normal range by the end of the dosing interval. The Endocrine Society Clinical Practice Guideline notes that these peaks and valleys “may be associated with fluctuations in symptoms.”

More frequent administration (typically twice weekly, or approximately every 3.5 days) reduces the size of each dose and therefore the amplitude of the peak-to-trough swing. Clinical and pharmacokinetic observations support several practical benefits of this approach:

  • More stable day-to-day testosterone levels, which many patients experience as steadier energy, mood, and libido.

  • These are many of the same improvements experienced by men seeking treatment for low testosterone symptoms. 

  • Reduced acute rises that can drive higher aromatization to estradiol.

  • Potentially lower stimulation of erythropoiesis. Larger peaks from less frequent dosing have been linked to greater elevations in hematocrit in comparative data.

In clinical practice, splitting a weekly total dose of testosterone cypionate into two injections is a simple, low-cost way to approximate more physiologic exposure. We routinely monitor trough testosterone, hematocrit, estradiol, and symptoms to fine-tune both the total weekly dose and the frequency for each patient.

A practical schedule we often recommend is Sunday and Thursday. Injecting on Sunday helps support stable levels heading into the work week, while the Thursday dose helps maintain energy and well-being through the weekend.

Subcutaneous vs Intramuscular Injections: What the Data Show

Both routes can effectively deliver testosterone cypionate and raise serum levels into the target range. However, published studies demonstrate important differences in tolerability, convenience, and certain laboratory outcomes.

Efficacy and pharmacokinetics

Multiple studies show that subcutaneous injection of testosterone esters (including cypionate) produces mean serum testosterone concentrations comparable to intramuscular injection when similar doses are used.

A 2018 prospective crossover study found total testosterone exposure (area under the curve) was statistically similar between the two routes.

Safety profile and laboratory parameters

A 2022 comparison of intramuscular testosterone cypionate versus a subcutaneous testosterone formulation found that the subcutaneous modality was independently associated with lower post-therapy estradiol and hematocrit levels after adjustment for covariates.

Patient preference and tolerability

Patients consistently prefer the subcutaneous route when they have experienced both. In a study of individuals who switched from IM to subQ, all preferred subcutaneous injections; the majority expressed a marked preference. SubQ was associated with lower scores for pre-injection anxiety, pain during injection, and post-injection discomfort.

Additional advantages of the subcutaneous route include:

  • Smaller needle size (we typically use 25–27 gauge needles), which is associated with less discomfort and less scar tissue formation compared with the larger needles often required for intramuscular injections.

  • Easier self-administration technique.

  • Ability to inject into abdominal fat or other accessible subcutaneous sites rather than large muscle groups.

  • High rates of successful long-term self-injection after proper training.

Local reactions are generally mild and transient. Serious complications are rare with either route when proper sterile technique is followed.

Our Approach at Affinity Whole Health

We exclusively use testosterone cypionate. Many of our patients do well with twice-weekly (or more frequent) subcutaneous injections on a Sunday and Thursday schedule. This combination often provides:

  • Stable hormone levels with fewer peaks and troughs.

  • Convenient self-administration at home after in-clinic training and instruction.

  • A favorable profile for estradiol and hematocrit in many individuals.

  • Flexibility to adjust dosing based on symptoms and laboratory monitoring.

We only use FDA-approved testosterone cypionate formulations dispensed through licensed pharmacies and follow current regulatory requirements. Every patient receives education on proper injection technique, site rotation, and safety. We monitor total and free testosterone, hematocrit, estradiol, PSA, and clinical response at regular intervals.

Safety Considerations

Injectable testosterone cypionate is FDA-approved for the treatment of hypogonadism due to medical conditions. As with any TRT, potential side effects include elevated hematocrit, changes in estradiol, injection-site reactions, and suppression of natural testosterone production. Contraindications and precautions follow standard guidelines (e.g., untreated severe sleep apnea, elevated baseline hematocrit, certain prostate conditions, and desire for near-term fertility without concurrent fertility-preserving measures).

We screen carefully and adjust protocols to keep therapy safe and effective.

Ready to Optimize Your TRT Protocol?

If you are considering testosterone therapy or are already on injections and want to explore whether a twice-weekly schedule or a switch to subcutaneous administration could improve your results and experience, we are here to help. Our team specializes in evidence-based, individualized hormone optimization with careful laboratory monitoring and practical support for self-administration of testosterone cypionate.

Schedule a consultation to review your labs, symptoms, and goals. Together we can design a protocol that prioritizes both effectiveness and day-to-day quality of life.

This content is for educational purposes only and does not constitute medical advice. Testosterone therapy should only be prescribed and monitored by a qualified healthcare provider after appropriate evaluation and confirmation of testosterone deficiency. Individual results vary. Always discuss benefits, risks, and the most suitable regimen with your clinician.

Key Published References

Chris Lyons
Next

NAD+ Therapy: Benefits, Science, and Who May Benefit